CORRECTION article

Front. Pharmacol.

Sec. Pharmacology of Anti-Cancer Drugs

Correction: Fibroblast growth factor receptor inhibitors in glioma: a narrative review of recent advances

  • 1. Sichuan University, Chengdu, China

  • 2. The Second Xiangya Hospital of Central South University, Changsha, China

  • 3. Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

  • 4. Affiliated Hospital of Guangdong Medical University, Zhanjiang, China

  • 5. Chengdu University of Traditional Chinese Medicine, Chengdu, China

The final, formatted version of the article will be published soon.

Abstract

Correction on: Han M, Zhou Z, Qian B, Zhang Y, Peng C and Peng F (2026) Fibroblast growth factor receptor inhibitors in glioma: a narrative review of recent advances. Front. Pharmacol. 16:1714696. doi: 10.3389/fphar.2025.1714696

Summary

Keywords

fibroblast growth factor receptor (FGFR), Gene Fusion, Glioma, inhibitors, pathways

Received

14 February 2026

Accepted

18 February 2026

Copyright

© 2026 Han, Zhou, Qian, Zhang, Peng and Peng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yuanqi Zhang; Fu Peng

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics